Deferred Tax Assets, Valuation Allowance of MEDICINOVA INC from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
MEDICINOVA INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • MEDICINOVA INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $81,022,903, a 4% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

MEDICINOVA INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $81,022,903 -$3,377,023 -4% 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q4 2024 $84,399,926 +$1,033,086 +1.2% 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q4 2023 $83,366,840 +$1,008,018 +1.2% 31 Dec 2023 10-K 10 Mar 2026 2025 FY
Q4 2022 $82,358,822 +$3,697,210 +4.7% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q4 2021 $78,661,612 -$356,594 -0.45% 31 Dec 2021 10-K/A 28 Mar 2023 2022 FY
Q4 2020 $79,018,206 +$2,965,464 +3.9% 31 Dec 2020 10-K 16 Feb 2022 2021 FY
Q4 2019 $76,052,742 -$258 0% 31 Dec 2019 10-K 19 Feb 2021 2020 FY
Q4 2018 $76,053,000 +$1,947,000 +2.6% 31 Dec 2018 10-K 13 Feb 2020 2019 FY
Q4 2017 $74,106,000 -$27,880,000 -27% 31 Dec 2017 10-K 13 Feb 2020 2019 FY
Q4 2016 $101,986,000 +$938,000 +0.93% 31 Dec 2016 10-K 13 Feb 2018 2017 FY
Q4 2015 $101,048,000 +$1,198,000 +1.2% 31 Dec 2015 10-K 13 Feb 2018 2017 FY
Q4 2014 $99,850,000 +$3,072,000 +3.2% 31 Dec 2014 10-K 14 Feb 2017 2016 FY
Q4 2013 $96,778,000 +$1,304,000 +1.4% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q4 2012 $95,474,000 +$5,685,000 +6.3% 31 Dec 2012 10-K 27 Mar 2014 2013 FY
Q4 2011 $89,789,000 31 Dec 2011 10-K 28 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.